+467.0%
MRNA vs EQIX
+35.5%
+431.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EQIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +4.8% |
| 7D | -1.1% | +0.2% | -1.3% | -1.2% |
| 30D | +126.1% | -2.5% | +128.6% | +127.6% |
| 3M | +190.0% | 0.0% | +190.1% | +184.6% |
| 6M | +157.2% | +7.6% | +149.6% | +139.4% |
| YTD | +388.2% | +37.5% | +350.7% | +237.5% |
| 1Y | +467.0% | +32.9% | +434.1% | +325.6% |
| All | +467.0% | +35.5% | +431.5% | +325.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EQIX.
Daily Out/Under-Performance
Portfolio return minus EQIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EQIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EQIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling